Clinical Trial Update: Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating stereotactic body radiotherapy for oligoprogression in metastatic non-small cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Metastatic Non-Small Cell Lung Cancer, NSCLC Stage IV | Phase 3 | Status: RECRUITING